Market Share of Mergers And Acquisitions In The Diabetes Industry
Some prominent players in the market are Medtronic, Eli Lily, Sanofi, Dexcom, and Novo Nordisk, among others. Mergers and acquisitions between players in the recent past helped companies strengthen their market presence and develop capabilities that are novel to the companies. For instance, in July 2021, Eli Lily and Company announced the acquisition of Protomer Technologies Inc. to focus on advancing glucose-responsive insulins and accelerate the development of next-generation protein therapeutics.
Mergers And Acquisitions In The Diabetes Market Leaders
-
Eli Lily and Company
-
Sanofi Aventis
-
Dexcom
-
Novo Nordisk
-
Medtronic
*Disclaimer: Major Players sorted in no particular order
